Table 2 Baseline characteristic of participants
Characteristic | Groups | P-value | |||
|---|---|---|---|---|---|
Group 1 (N = 19) | Group 2 (N = 19) | Group 3 (N = 17) | Group 4 (N = 19) | ||
Gender (female/male) | (16/4) | (16/4) | (16/4) | (16/4) | Â |
Age | 36.20 ± 1.89 | 37.10 ± 1.78 | 36.90 ± 1.84 | 36.45 ± 1.87 | 0.97 |
Weight (kg) | 69.45 ± 2.75 | 71.65 ± 3.80 | 69.25 ± 2.51 | 70.95 ± 2.31 | 0.92 |
Height (cm) | 162.70 ± 1.92 | 161.25 ± 1.76 | 162.80 ± 1.97 | 162.20 ± 1.52 | 0.92 |
WC (cm) | 79.80 ± 1.57 | 83.30 ± 2.20 | 80.60 ± 1.67 | 83.20 ± 1.65 | 0.39 |
BMI (kg/m2) | 26.23 ± 0.94 | 27.29 ± 1.04 | 26.17 ± 0.84 | 27.13 ± 0.87 | 0.75 |
EI(kcal) | 1612.12 ± 173.04 | 1703.79 ± 215.20 | 1592.36 ± 105.53 | 1410.69 ± 68.15 | 0.11 |
VCAM gene expression | 15.67 ± 0.53 | 15.74 ± 0.74 | 15.55 ± 0.89 | 14.58 ± 0.69 | 0.92 |
Serum VCAM concentration (ng/dl) | 4.90 ± 1.15 | 4.18 ± 0.72 | 4.75 ± 1.06 | 4.94 ± 1.22 | 0.99 |
Headache attacks (number per week) | 2.81 ± 0.31 | 2.77 ± 0.26 | 2.72 ± 0.40 | 2.76 ± 0.24 | 0.99 |
Headache severity (scoring from 0–10) | 7.52 ± 0.44 | 7.36 ± 0.46 | 7.47 ± 0.48 | 7.39 ± 0.46 | 0.99 |
Headache duration (hours) | 7.44 ± 1.80 | 7.68 ± 1.77 | 7.28 ± 1.77 | 7.34 ± 1.43 | 0.99 |